These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32979864)

  • 1. FLI1 and ERG protein degradation is regulated via Cathepsin B lysosomal pathway in human dermal microvascular endothelial cells.
    Mazzotta C; Marden G; Farina A; Bujor A; Trojanowski MA; Trojanowska M
    Microcirculation; 2021 Jan; 28(1):e12660. PubMed ID: 32979864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis.
    Looney AP; Han R; Stawski L; Marden G; Iwamoto M; Trojanowska M
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):121-131. PubMed ID: 28248553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
    Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
    J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
    Saigusa R; Asano Y; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    Br J Dermatol; 2016 Feb; 174(2):338-47. PubMed ID: 26399195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway.
    Stawski L; Marden G; Trojanowska M
    J Immunol; 2018 Jan; 200(1):248-259. PubMed ID: 29141862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
    Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    PLoS One; 2012; 7(2):e32272. PubMed ID: 22384200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma.
    Miyagawa T; Ichimura Y; Nakamura K; Hirabayashi M; Yamashita T; Saigusa R; Miura S; Takahashi T; Toyama T; Taniguchi T; Akamata K; Yoshizaki A; Sato S; Asano Y
    J Dermatol Sci; 2018 Nov; 92(2):207-214. PubMed ID: 30268392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis.
    Akamata K; Asano Y; Taniguchi T; Yamashita T; Saigusa R; Nakamura K; Noda S; Aozasa N; Toyama T; Takahashi T; Ichimura Y; Sumida H; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2015 Jul; 54(7):1308-16. PubMed ID: 25539827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.
    Asano Y; Stawski L; Hant F; Highland K; Silver R; Szalai G; Watson DK; Trojanowska M
    Am J Pathol; 2010 Apr; 176(4):1983-98. PubMed ID: 20228226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inhibitor of endothelial ETS transcription factors promotes physiologic and therapeutic vessel regression.
    Schafer CM; Gurley JM; Kurylowicz K; Lin PK; Chen W; Elliott MH; Davis GE; Bhatti F; Griffin CT
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26494-26502. PubMed ID: 33020273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.
    Taniguchi T; Miyagawa T; Tamaki Z; Nakamura K; Yamashita T; Saigusa R; Takahashi T; Toyama T; Ichimura Y; Yoshizaki A; Tada Y; Sugaya M; Kadono T; Sato S; Asano Y
    Arch Dermatol Res; 2017 Dec; 309(10):833-842. PubMed ID: 29038846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.
    Saigusa R; Asano Y; Taniguchi T; Hirabayashi M; Nakamura K; Miura S; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Trojanowska M; Sato S
    Arthritis Res Ther; 2018 Feb; 20(1):23. PubMed ID: 29415756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of c-Abl/protein kinase C-δ/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma.
    Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Br J Dermatol; 2012 Nov; 167(5):1098-105. PubMed ID: 22591006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins.
    Cermak S; Kosicek M; Mladenovic-Djordjevic A; Smiljanic K; Kanazir S; Hecimovic S
    PLoS One; 2016; 11(11):e0167428. PubMed ID: 27902765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
    Miyagawa T; Taniguchi T; Saigusa R; Fukayama M; Takahashi T; Yamashita T; Hirabayashi M; Miura S; Nakamura K; Yoshizaki A; Sato S; Asano Y
    Rheumatology (Oxford); 2020 Aug; 59(8):2005-2015. PubMed ID: 31782787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
    Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    Exp Dermatol; 2016 Apr; 25(4):287-92. PubMed ID: 26661692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability.
    Akamata K; Asano Y; Yamashita T; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
    Arthritis Rheumatol; 2015 May; 67(5):1335-44. PubMed ID: 25707716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1.
    Bujor AM; Haines P; Padilla C; Christmann RB; Junie M; Sampaio-Barros PD; Lafyatis R; Trojanowska M
    Int J Mol Med; 2012 Dec; 30(6):1473-80. PubMed ID: 23041765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.